Risk factor
Negligible price volatility
Profitability factor
Solid dividends
In Guru Portfolios
About
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, underpriced on P/FCF.
Target Price
The average target price of SNY is 57.3 and suggests 43% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas